Company intelligence / Profile preview

Northwest Biotherapeutics

Bethesda, Maryland, United Statesnwbio.com ↗

Ownership: Public · NWBO
Employees: ~25
Development stage: Other

Overview

Northwest Biotherapeutics’ lead product candidate DCVax-L has completed a 331-patient Phase III trial for glioblastoma multiforme. Results have been published in JAMA Oncology and presented at scientific meetings. The company has submitted a Marketing Authorization Application (MAA) for commercial approval of DCVax-L. DCVax-Direct completed a Phase I trial for inoperable solid tumors and may advance to Phase II as resources permit. The company previously conducted early trials with DCVax-L for advanced ovarian cancer

Therapeutic areas: Oncology
Modalities: Dendritic cell-based vaccines (cell therapy/immunotherapy)
Industry: Biotech

Drug pipeline

18 assets

DCVax-L

17 more assets in the full pipeline.

Partnerships

No major pharma partnerships disclosed; prior collaborations with academic centers such as University of California Los Angeles and University of Pennsylvania are noted.

Financials

Market cap: $272.9M
Total revenue: $1.4M
Enterprise value: $328.7M

Beyond the preview

Go deeper on Northwest Biotherapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northwest Biotherapeutics.